Newsletter Subscription

Enter Name and Email

12 January 2015 - Neurolixis announces drug discovery collaboration with Krakow University

Neurolixis, a bioscience company co-founded by Adrian Newman-Tancredi, has announced a drug discovery collaboration with Jagiellonian University in Krakow, Poland. The collaboration will synthesize and test novel chemical entities aimed at treating serious central nervous system disorders such as depression and schizophrenia. In his role as Chief Scientific Officer of Neurolixis, Dr. Newman-Tancredi will jointly lead the collaboration with scientists at the Pharmacy Faculty of Jagiellonian University.

See the Neurolixis press release here.